Epstein Secrets

8 2009 2010 2011 2012 2013 2014 2015 2016 2017 GP-led secondaries GP-led secondaries as % of total (1) Source: Glendower Capital analysis based on Greenhill Secondary Market Trends & Outlook, January 2018; and Dow Jones Private Equity Analyst Guide to the Secondary Market, June 2017. STRICTLY CONFIDENTIAL 35 2.7 2.7

Proprietary Alternative Funds Family Office N/A Alternative Funds Alternative Funds N/A Alternative Funds Public to Private EFTA01396871 Limited Process SWF Deal type GP-led Secondary Single Asset Deal Fund Secondary Fund Secondary Fund Secondary GP-led Secondary GP-led Secondary Single Asset Dea

8 2009 2010 2011 2012 2013 2014 2015 2016 2017 GP-led secondaries GP-led secondaries as % of total (1) Source: Glendower Capital analysis based on Greenhill Secondary Market Trends & Outlook, January 2018; and Dow Jones Private Equity Analyst Guide to the Secondary Market, June 2017. STRICTLY CONFIDENTIAL 35 2.7 2.7

Proprietary Alternative Funds Family Office N/A Alternative Funds Alternative Funds N/A Alternative Funds Public to Private EFTA01397544 Limited Process SWF Deal type GP-led Secondary Single Asset Deal Fund Secondary Fund Secondary Fund Secondary GP-led Secondary GP-led Secondary Single Asset Dea

8 2009 2010 2011 2012 2013 2014 2015 2016 2017 GP-led secondaries GP-led secondaries as % of total (1) Source: Glendower Capital analysis based on Greenhill Secondary Market Trends & Outlook, January 2018; and Dow Jones Private Equity Analyst Guide to the Secondary Market, June 2017. STRICTLY CONFIDENTIAL 35 2.7 2.7

Proprietary Alternative Funds Family Office N/A Alternative Funds Alternative Funds N/A Alternative Funds Public to Private EFTA01396194 Limited Process SWF Deal type GP-led Secondary Single Asset Deal Fund Secondary Fund Secondary Fund Secondary GP-led Secondary GP-led Secondary Single Asset Dea